Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Fracasso · SciRah

Researcher profile · Semantic Scholar

P. Fracasso

Share profile

P. Fracasso — researcher profile on SciRah

h-index: 35
Works: 134
Citations: 4,003

Most-cited papers

A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors
Kwok-Kin Wong, P. Fracasso, R. Bukowski, T. Lynch +14 more
2009Clinical Cancer Research289 citations Open access
Semantic Scholar
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
R. Aft, M. Naughton, K. Trinkaus, M. Watson +20 more
2010The Lancet Oncology270 citations Open access
Semantic Scholar
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial
D. Hong, B. Van Tine, S. Biswas, C. McAlpine +40 more
2023Nature Medicine186 citations Open access
Semantic Scholar
A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing
P. Fracasso, H. Burris, M. Arquette, R. Govindan +15 more
2007Clinical Cancer Research157 citations Open access
Semantic Scholar
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer.
C. Lhommé, F. Joly, J. Walker, A. Lissoni +8 more
2008Journal of Clinical Oncology149 citations
Semantic Scholar
A phase II study of bortezomib in the treatment of metastatic malignant melanoma
Svetomir N. Markovic, S. Geyer, F. Dawkins, W. Sharfman +7 more
2005Cancer142 citations Open access
Semantic Scholar
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
Cynthia X. Ma, M. Ellis, G. Petroni, Zhan-Fang Guo +18 more
2012Breast Cancer Research and Treatment111 citations Open access
Semantic Scholar
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer.
J. Mayadev, Danielle M. Enserro, Yvonne G. Lin, Diane M. Da Silva +7 more
2019JAMA Oncology88 citations Open access
Semantic Scholar
Correlating EGFR Expression with Receptor-Binding Properties and Internalization of 64Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines
Martin Eiblmaier, Laura A. Meyer, M. Watson, P. Fracasso +2 more
2008Journal of Nuclear Medicine86 citations Open access
Semantic Scholar
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma
H. Bailey, M. Mahoney, D. Ettinger, W. Maples +4 more
2006Cancer80 citations Open access
Semantic Scholar
A Phase II study of Dovitinib in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
P. Dillon, G. Petroni, B. Horton, C. Moskaluk +5 more
2017Clinical Cancer Research75 citations Open access
Semantic Scholar
Phase II Study of Axalimogene Filolisbac (ADXS-HPV) for Platinum-Refractory Cervical Carcinoma: an NRG Oncology/Gynecologic Oncology Group Study
W. Huh, W. Brady, P. Fracasso, D. Dizon +9 more
2020Gynecologic Oncology71 citations Open access
Semantic Scholar
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)
P. Thaker, R. Salani, W. Brady, H. Lankes +12 more
2016Annals of Oncology71 citations Open access
Semantic Scholar
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies
P. Fracasso, Kerry J Williams, Ronald Chen, J. Picus +22 more
2010Cancer Chemotherapy and Pharmacology70 citations Open access
Semantic Scholar
HKI-272, an irreversible pan erbB receptor tyrosine kinase inhibitor: Preliminary phase 1 results in patients with solid tumors.
K. Wong, P. Fracasso, R. Bukowski, P. Munster +5 more
2006Journal of Clinical Oncology60 citations
Semantic Scholar
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.
P. Fracasso, J. Blessing, K. Molpus, L. M. Adler +2 more
2006Gynecologic Oncology59 citations
Semantic Scholar
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncolog
P. Thaker, W. Brady, H. Lankes, K. Odunsi +7 more
2017Gynecologic Oncology52 citations Open access
Semantic Scholar
Low dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group
C. Kunos, M. Sill, Thomas E. Buekers, J. Walker +5 more
2011Gynecologic Oncology50 citations Open access
Semantic Scholar
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer
G. Blumenschein, S. Devarakonda, M. Johnson, V. Moreno +23 more
2022Journal for ImmunoTherapy of Cancer48 citations Open access
Semantic Scholar
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies
P. Fracasso, J. Picus, J. Wildi, S. A. Goodner +11 more
2009Cancer Chemotherapy and Pharmacology43 citations
Semantic Scholar
A Phase I Trial of Pegylated Liposomal Doxorubicin (PLD), Carboplatin, Bevacizumab and Veliparib in Recurrent, Platinum-Sensitive Ovarian, Primary Peritoneal, and Fallopian Tube Cancer: An NRG Oncology/Gynecologic Oncology Group study
L. Landrum, W. Brady, D. Armstrong, K. Moore +5 more
2015Gynecologic Oncology41 citations Open access
Semantic Scholar
Safety Lead-In of the MEK Inhibitor Trametinib in Combination with GSK2141795, an AKT Inhibitor, in Patients with Recurrent Endometrial Cancer: An NRG Oncology/GOG Study
S. Westin, M. Sill, R. Coleman, S. Waggoner +11 more
2019Gynecologic Oncology39 citations Open access
Semantic Scholar
Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.
I. Vergote, Agustin Garcia, J. Micha, C. Pippitt +15 more
2013Journal of Clinical Oncology39 citations Open access
Semantic Scholar
Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemo-immunotherapy
B. Monk, A. Facciabene, W. Brady, C. Aghajanian +10 more
2016Clinical Cancer Research36 citations Open access
Semantic Scholar
A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study.
K. Moore, M. Sill, D. Miller, C. McCourt +7 more
2012Gynecologic Oncology35 citations
Semantic Scholar
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Rui Wang, Chan Gao, M. Raymond, Gennaro Dito +20 more
2019Clinical Cancer Research34 citations Open access
Semantic Scholar
Phase I dose escalation and expansion trial to assess the safety and efficacy of ADP-A2M4 SPEAR T cells in advanced solid tumors.
D. Hong, B. Van Tine, A. Olszanski, M. Johnson +11 more
2020Journal of Clinical Oncology33 citations
Semantic Scholar
A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human αv integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer
F. Chu, J. Picus, P. Fracasso, R. Dreicer +2 more
2011Investigational new drugs33 citations
Semantic Scholar
Evaluation of epothilone B analog in advanced soft tissue sarcoma: a phase II study of the phase II consortium.
S. Okuno, W. Maples, M. Mahoney, T. Fitch +6 more
2005Journal of Clinical Oncology31 citations
Semantic Scholar
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar
P. Fracasso, K. Blum, Margaret K. Ma, Benjamin R. Tan +11 more
2005British Journal of Cancer30 citations Open access
Semantic Scholar
Reversible posterior leukoencephalopathy syndrome during regorafenib treatment: a case report and literature review of reversible posterior leukoencephalopathy syndrome associated with multikinase inhibitors.
Zaw W. Myint, J. Sen, Nicole L. Watts, T. Druzgal +4 more
2014Clinical colorectal cancer29 citations
Semantic Scholar
Coaching intervention as a strategy for minority recruitment to cancer clinical trials.
P. Fracasso, S. A. Goodner, Allison N. Creekmore, H. Morgan +7 more
2013Journal of Oncology Practice29 citations Open access
Semantic Scholar
A phase I study of sequential ipilimumab in the definitive treatment of node positive cervical cancer: GOG 9929.
J. Mayadev, W. Brady, Yvonne G. Lin, Diane M. Da Silva +11 more
201728 citations
Semantic Scholar
A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
K. Bell-McGuinn, W. Brady, R. Schilder, P. Fracasso +8 more
201523 citations
Semantic Scholar
A Phase I Study of Concurrent Weekly Topotecan and Cisplatin Chemotherapy with Whole Pelvic Radiation Therapy in Locally Advanced Cervical Cancer: a Gynecologic Oncology Group Study
Peter G. Rose, M. Sill, D. Mcmeekin, Amina Ahmed +5 more
2011Gynecologic Oncology23 citations Open access
Semantic Scholar
A Phase I Study of Bexarotene and Rosiglitazone in Patients with Refractory Cancers
W. Read, M. Baggstrom, P. Fracasso, R. Govindan
2008Chemotherapy23 citations
Semantic Scholar
A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study,
D. Jandial, W. Brady, S. Howell, H. Lankes +12 more
2017Gynecologic Oncology20 citations Open access
Semantic Scholar
Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group Study
Don S. Dizon, M. Sill, Natalie S. Gould, S. Rubin +6 more
2011Gynecologic Oncology19 citations Open access
Semantic Scholar
Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors
D. Hong, M. Butler, R. Pachynski, R. Sullivan +21 more
2022Frontiers in Oncology18 citations Open access
Semantic Scholar
A Phase I Evaluation of Extended Field Radiation Therapy with Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women with Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologic Oncology Group study
C. Boardman, W. Brady, D. Dizon, C. Kunos +6 more
2018Gynecologic Oncology18 citations Open access
Semantic Scholar
The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapies.
K. Simonsen, P. Fracasso, S. Bernstein, M. Wind-Rotolo +4 more
2018European Journal of Cancer16 citations Open access
Semantic Scholar
A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study,,
Natalie S. Gould, M. Sill, R. Mannel, P. Thaker +8 more
2011Gynecologic Oncology16 citations Open access
Semantic Scholar
FRACTION (Fast Real-time Assessment of Combination Therapies in Immuno-Oncology)-gastric cancer (GC): A randomized, open-label, adaptive, phase 2 study of nivolumab in combination with other immuno-oncology (IO) agents in patients with advanced GC.
P. Aanur, M. Gutierrez, R. Kelly, J. Ajani +8 more
201715 citations
Semantic Scholar
A phase 2 study of live-attenuated listeria monocytogenes cancer immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265).
W. Huh, W. Brady, K. Moore, H. Lankes +6 more
201214 citations
Semantic Scholar
A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group Study
Natalie S. Gould, M. Sill, R. Mannel, P. Thaker +6 more
2012Gynecologic Oncology13 citations Open access
Semantic Scholar
Sequence dependence of hematologic toxicity using carboplatin and topotecan for primary therapy of advanced epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.
M. Bookman, D. Mcmeekin, P. Fracasso
2006Gynecologic Oncology13 citations
Semantic Scholar
A PHASE I STUDY OF INTRAVENOUS OR INTRAPERITONEAL PLATINUM BASED CHEMOTHERAPY IN COMBINATION WITH VELIPARIB AND BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN, PRIMARY PERITONEAL AND FALLOPIAN TUBE CANCER
K. Moore, Austin Miller, K. Bell-McGuinn, R. Schilder +13 more
2019Gynecologic Oncology12 citations Open access
Semantic Scholar
1194 CHARACTERIZATION OF VIRAL ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH BMS-791325 AND PEGYLATED INTERFERON-ALFA AND RIBAVIRIN
D. McPhee, P. Falk, P. Fracasso, J. Lemm +6 more
201212 citations
Semantic Scholar
379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor
D. Hong, J. Clarke, T. Johanns, P. Kebriaei +19 more
202011 citations Open access
Semantic Scholar
A Phase I Trial of Dose Dense (Biweekly) Carboplatin Combined with Paclitaxel and Pegfilgrastim: A Feasibility Study in Patients with Untreated Stage III and IV Ovarian, Tubal or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
A. Tiersten, M. Sill, D. Knight, F. Muggia +5 more
2010Gynecologic Oncology10 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Moore×11
Invite
K. Moore — researcher profile on SciRah
C. Aghajanian×10
Invite
C. Aghajanian — researcher profile on SciRah
W. Brady×10
Invite
W. Brady — researcher profile on SciRah
J. Walker×8
Invite
J. Walker — researcher profile on SciRah

×8

Invite

R. Schilder — researcher profile on SciRah

Invite

H. Lankes — researcher profile on SciRah

Invite

M. Sill — researcher profile on SciRah

Invite

R. Mannel — researcher profile on SciRah

Invite

M. Ellis — researcher profile on SciRah

Invite

J. Navenot — researcher profile on SciRah

Invite

E. Norry — researcher profile on SciRah

S. A. Goodner×5

Invite

S. A. Goodner — researcher profile on SciRah